Nomura set a $80.00 target price on shares of Danaher Corp. (NYSE:DHR) stock in a research note issued on Friday, StockRatingsNetwork reports. Nomura’s price target indicates a potential upside of 18.08% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Danaher Corp. in a research note to investors on Friday, July 12th. They now have a $72.00 price target on the stock. Separately, analysts at Sanford C. Bernstein raised their price target on shares of Danaher Corp. from $73.00 to $74.00 in a research note to investors on Thursday, July 11th. They now have an “outperform” rating on the stock. Finally, analysts at William Blair reiterated an “outperform” rating on shares of Danaher Corp. in a research note to investors on Wednesday, July 10th.
Five analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company’s stock. Danaher Corp. currently has a consensus rating of “Buy” and a consensus price target of $67.43.
Shares of Danaher Corp. (NYSE: DHR) opened at 67.75 on Friday. Danaher Corp. has a one year low of $49.76 and a one year high of $69.00. The stock’s 50-day moving average is currently $63.91. The company has a market cap of $46.931 billion and a P/E ratio of 19.47.
Danaher Corp. (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 18th. The company reported $0.87 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.85 by $0.02. The company had revenue of $4.70 billion for the quarter, compared to the consensus estimate of $4.72 billion. During the same quarter in the prior year, the company posted $0.84 earnings per share. The company’s quarterly revenue was up 4.0% on a year-over-year basis. Danaher Corp. has set its FY13 guidance at $3.37-3.42 EPS. Analysts expect that Danaher Corp. will post $3.41 EPS for the current fiscal year.
Danaher Corporation (NYSE: DHR) designs, manufactures and markets professional, medical, industrial and commercial products and services.